439 related articles for article (PubMed ID: 29748371)
81. Potential biomarker of circulating hsa-miR-1273g-3p level for detection of recurrent epithelial ovarian cancer.
Günel T; Gumusoglu E; Dogan B; Ertem FB; Hosseini MK; Cevik N; Senol T; Topuz S; Aydinli K
Arch Gynecol Obstet; 2018 Dec; 298(6):1173-1180. PubMed ID: 30264202
[TBL] [Abstract][Full Text] [Related]
82. MicroRNA‑195 suppresses cell proliferation, migration and invasion in epithelial ovarian carcinoma via inhibition of the CDC42/CCND1 pathway.
Hao X; Jia Q; Yuan J; Shi X; Guo H; Gao J; Guo Y
Int J Mol Med; 2020 Nov; 46(5):1862-1872. PubMed ID: 32901852
[TBL] [Abstract][Full Text] [Related]
83. Downregulation of miR-1294 associates with prognosis and tumor progression in epithelial ovarian cancer.
Guo TY; Xu HY; Chen WJ; Wu MX; Dai X
Eur Rev Med Pharmacol Sci; 2018 Nov; 22(22):7646-7652. PubMed ID: 30536306
[TBL] [Abstract][Full Text] [Related]
84. miR-144 Potentially Suppresses Proliferation and Migration of Ovarian Cancer Cells by Targeting RUNX1.
Han S; Zhu J; Zhang Y
Med Sci Monit Basic Res; 2018 Feb; 24():40-46. PubMed ID: 29445078
[TBL] [Abstract][Full Text] [Related]
85. MiR-652-3p is upregulated in non-small cell lung cancer and promotes proliferation and metastasis by directly targeting Lgl1.
Yang W; Zhou C; Luo M; Shi X; Li Y; Sun Z; Zhou F; Chen Z; He J
Oncotarget; 2016 Mar; 7(13):16703-15. PubMed ID: 26934648
[TBL] [Abstract][Full Text] [Related]
86. Extracellular Vesicle-Packaged circATP2B4 Mediates M2 Macrophage Polarization via miR-532-3p/SREBF1 Axis to Promote Epithelial Ovarian Cancer Metastasis.
Wang F; Niu Y; Chen K; Yuan X; Qin Y; Zheng F; Cui Z; Lu W; Wu Y; Xia D
Cancer Immunol Res; 2023 Feb; 11(2):199-216. PubMed ID: 36512324
[TBL] [Abstract][Full Text] [Related]
87. CKS2 promotes tumor progression and metastasis and is an independent predictor of poor prognosis in epithelial ovarian cancer.
Xu JH; Wang Y; Xu D
Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3225-3234. PubMed ID: 31081074
[TBL] [Abstract][Full Text] [Related]
88. miR-99a promotes proliferation targeting FGFR3 in human epithelial ovarian cancer cells.
Jiang H; Qu L; Wang Y; Cong J; Wang W; Yang X
Biomed Pharmacother; 2014 Mar; 68(2):163-9. PubMed ID: 24456664
[TBL] [Abstract][Full Text] [Related]
89. The downregulation of miR-509-3p expression by collagen type XI alpha 1-regulated hypermethylation facilitates cancer progression and chemoresistance via the DNA methyltransferase 1/Small ubiquitin-like modifier-3 axis in ovarian cancer cells.
Wu YH; Huang YF; Wu PY; Chang TH; Huang SC; Chou CY
J Ovarian Res; 2023 Jun; 16(1):124. PubMed ID: 37386587
[TBL] [Abstract][Full Text] [Related]
90. Up-regulation of stromal versican expression in advanced stage serous ovarian cancer.
Ghosh S; Albitar L; LeBaron R; Welch WR; Samimi G; Birrer MJ; Berkowitz RS; Mok SC
Gynecol Oncol; 2010 Oct; 119(1):114-20. PubMed ID: 20619446
[TBL] [Abstract][Full Text] [Related]
91. CircCERS6 Suppresses the Development of Epithelial Ovarian Cancer Through Mediating miR-630/RASSF8.
Li X; Jiang X; Lu J; Lin Y; Jiang L; Li Y; Wan F; Wang C
Biochem Genet; 2022 Dec; 60(6):2611-2629. PubMed ID: 35676548
[TBL] [Abstract][Full Text] [Related]
92. MiR-1182 inhibited metastasis and proliferation of ovarian cancer by targeting hTERT.
Hou XS; Han CQ; Zhang W
Eur Rev Med Pharmacol Sci; 2018 Mar; 22(6):1622-1628. PubMed ID: 29630105
[TBL] [Abstract][Full Text] [Related]
93. MicroRNA-494-3p targets CXCR4 to suppress the proliferation, invasion, and migration of prostate cancer.
Shen PF; Chen XQ; Liao YC; Chen N; Zhou Q; Wei Q; Li X; Wang J; Zeng H
Prostate; 2014 May; 74(7):756-67. PubMed ID: 24644030
[TBL] [Abstract][Full Text] [Related]
94. Inhibition of Ovarian Epithelial Carcinoma Tumorigenesis and Progression by microRNA 106b Mediated through the RhoC Pathway.
Chen S; Chen X; Xiu YL; Sun KX; Zhao Y
PLoS One; 2015; 10(5):e0125714. PubMed ID: 25933027
[TBL] [Abstract][Full Text] [Related]
95. MicroRNA‑455 inhibits cell proliferation and invasion of epithelial ovarian cancer by directly targeting Notch1.
Xu L; Li H; Su L; Lu Q; Liu Z
Mol Med Rep; 2017 Dec; 16(6):9777-9785. PubMed ID: 29039517
[TBL] [Abstract][Full Text] [Related]
96. Down-regulation of miR-24-3p in colorectal cancer is associated with malignant behavior.
Gao Y; Liu Y; Du L; Li J; Qu A; Zhang X; Wang L; Wang C
Med Oncol; 2015 Jan; 32(1):362. PubMed ID: 25502080
[TBL] [Abstract][Full Text] [Related]
97. The hypoxia-related microRNA miR-199a-3p displays tumor suppressor functions in ovarian carcinoma.
Kinose Y; Sawada K; Nakamura K; Sawada I; Toda A; Nakatsuka E; Hashimoto K; Mabuchi S; Takahashi K; Kurachi H; Lengyel E; Kimura T
Oncotarget; 2015 May; 6(13):11342-56. PubMed ID: 25839163
[TBL] [Abstract][Full Text] [Related]
98. Epithelial ovarian cancer-secreted exosomal miR-222-3p induces polarization of tumor-associated macrophages.
Ying X; Wu Q; Wu X; Zhu Q; Wang X; Jiang L; Chen X; Wang X
Oncotarget; 2016 Jul; 7(28):43076-43087. PubMed ID: 27172798
[TBL] [Abstract][Full Text] [Related]
99. lncRNA CDKN2A-AS1 facilitates tumorigenesis and progression of epithelial ovarian cancer via modulating the SOSTDC1-mediated BMP-SMAD signaling pathway.
Zhao Q; Dong D; Chu H; Man L; Huang X; Yin L; Zhao D; Mu L; Gao C; Che J; Liu Q
Cell Cycle; 2021 Jun; 20(12):1147-1162. PubMed ID: 34110955
[TBL] [Abstract][Full Text] [Related]
100. MiR-221 increases osteosarcoma cell proliferation, invasion and migration partly through the downregulation of PTEN.
Zhu J; Liu F; Wu Q; Liu X
Int J Mol Med; 2015 Nov; 36(5):1377-83. PubMed ID: 26397386
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
